Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00003409
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT03964909
What this trial is testing

Resting-State Functional MRI in Glioma Patients Before and After Surgery

Who this might be right for
Brain MassGlioma
M.D. Anderson Cancer Center 29
Early research (Phase 1)Active Not RecruitingNCT05075993
What this trial is testing

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Who this might be right for
Metastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more
M.D. Anderson Cancer Center 352
Early research (Phase 1)Looking for participantsNCT05139056
What this trial is testing

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

Who this might be right for
Currently Only Enrolling Glioblastoma Patients at First Recurrence
City of Hope Medical Center 36
Not applicableStudy completedNCT04557072
What this trial is testing

Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis

Who this might be right for
Pheochromocytoma
Jagiellonian University 1,344
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Not applicableStudy completedNCT01715077
What this trial is testing

Study of Ipilimumab in the Immune System

Who this might be right for
Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
University Health Network, Toronto 4
Very early researchActive Not RecruitingNCT03044977
What this trial is testing

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor, MalignantNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting
David Bushnell 20
Not applicableUnknownNCT06050057
What this trial is testing

Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

Who this might be right for
Adrenal TumorAdrenal DiseaseAdrenal Mass+10 more
University Hospital Olomouc 100
Not applicableUnknownNCT05641012
What this trial is testing

Association Between Helioderma and Response to Immunotherapy in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Institut Jean-Godinot 100
Not applicableEnded earlyNCT03287063
What this trial is testing

Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University of Michigan Rogel Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00919737
What this trial is testing

Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme

Who this might be right for
Malignant Glioma
Nobelpharma 24
Not applicableUnknownNCT03593577
What this trial is testing

Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI

Who this might be right for
Vestibular Schwannoma
University Hospital, Strasbourg, France 185
Testing effectiveness (Phase 2)Study completedNCT02116777
What this trial is testing

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Who this might be right for
Adult Solid NeoplasmChildhood Solid NeoplasmRecurrent Childhood Central Nervous System Neoplasm+3 more
National Cancer Institute (NCI) 40
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Testing effectiveness (Phase 2)Looking for participantsNCT07288112
What this trial is testing

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Who this might be right for
Refractory Melanoma
Diakonos Oncology Corporation 35
Not applicableEnded earlyNCT02700763
What this trial is testing

[18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis

Who this might be right for
Melanoma
University Medical Center Groningen 1
Early research (Phase 1)Study completedNCT04334863
What this trial is testing

WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors

Who this might be right for
Brain TumorMedulloblastomaBrain Metastases
Emory University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03647163
What this trial is testing

Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerNeuroendocrine Carcinoma+1 more
Vyriad, Inc. 33
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Next Page